NET PROFIT (x1000 NOK)
EMPLOYEES
Biocrine AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
0
|
0
|
0 |
| Financial expenses |
56
|
4
|
34 |
| Earnings before taxes |
-9,385
|
-9,931
|
-7,046 |
| EBITDA |
-9,364
|
-9,992
|
-7,020 |
| Total assets |
14,588
|
13,468
|
19,962 |
| Current assets |
1,797
|
433
|
9,009 |
| Current liabilities |
1,418
|
3,676
|
1,546 |
| Equity capital |
13,170
|
9,792
|
18,416 |
| - share capital |
306
|
289
|
256 |
| Employees (average) |
8
|
8
|
8 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
90.3%
|
72.7%
|
92.3% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) |
-63.9%
|
-73.7%
|
-35.1% |
| Current ratio |
126.7%
|
11.8%
|
582.7% |
| Return on equity (ROE) |
-71.3%
|
-101.4%
|
-38.3% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.